메뉴 건너뛰기




Volumn 43, Issue 5, 2007, Pages 280-283

Plasma concentrations of lidocaine in dogs following lidocaine patch application

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 34249339966     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0430280     Document Type: Article
Times cited : (42)

References (9)
  • 1
    • 0036159190 scopus 로고    scopus 로고
    • Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing
    • Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36:236-240.
    • (2002) Ann Pharmacother , vol.36 , pp. 236-240
    • Gammaitoni, A.R.1    Davis, M.W.2
  • 2
    • 0037303831 scopus 로고    scopus 로고
    • Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: A review of the literature
    • Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 2003;43:111-117.
    • (2003) J Clin Pharmacol , vol.43 , pp. 111-117
    • Gammaitoni, A.R.1    Alvarez, N.A.2    Galer, B.S.3
  • 3
    • 0141652794 scopus 로고    scopus 로고
    • Pain control - lidocaine patch 5%
    • Pasero C. Pain control - lidocaine patch 5%. Am J Nurs 2003;103:75-78.
    • (2003) Am J Nurs , vol.103 , pp. 75-78
    • Pasero, C.1
  • 4
    • 13144279285 scopus 로고    scopus 로고
    • Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: Results of a pilot 2-week, open-label study using the neuropathic pain scale
    • Gammaitoni AR, Galer BS, Bradley S, et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 2004;20:13-19.
    • (2004) Curr Med Res Opin , vol.20 , pp. 13-19
    • Gammaitoni, A.R.1    Galer, B.S.2    Bradley, S.3
  • 5
    • 33645328574 scopus 로고    scopus 로고
    • Weiland L, Croubels S, Baert K, et al. Pharmacokinetics of a lidocaine patch 5% in dogs. J Vet Med, Series A, 2006;53:34-39.
    • Weiland L, Croubels S, Baert K, et al. Pharmacokinetics of a lidocaine patch 5% in dogs. J Vet Med, Series A, 2006;53:34-39.
  • 6
    • 13444273001 scopus 로고    scopus 로고
    • Effect of lidocaine on the minimum alveolar concentration of isoflurane in dogs
    • Valverde A, Doherty TJ, Hernandez J, et al. Effect of lidocaine on the minimum alveolar concentration of isoflurane in dogs. Vet Anaesth Analg 2004;31:264-271.
    • (2004) Vet Anaesth Analg , vol.31 , pp. 264-271
    • Valverde, A.1    Doherty, T.J.2    Hernandez, J.3
  • 7
    • 0020771135 scopus 로고
    • Determination of lidocaine concentrations producing therapeutic and toxic effects in dogs
    • Wilcke JR, Davis LE, Neff-Davis CA. Determination of lidocaine concentrations producing therapeutic and toxic effects in dogs. J Vet Pharmacol Therapeut 1983;6:105-111.
    • (1983) J Vet Pharmacol Therapeut , vol.6 , pp. 105-111
    • Wilcke, J.R.1    Davis, L.E.2    Neff-Davis, C.A.3
  • 8
    • 0035452136 scopus 로고    scopus 로고
    • Potential and problems of developing transdermal patches for veterinary applications
    • Riviere JE, Papich MG. Potential and problems of developing transdermal patches for veterinary applications. Adv Drug Deliv Rev 2001;50:175-203.
    • (2001) Adv Drug Deliv Rev , vol.50 , pp. 175-203
    • Riviere, J.E.1    Papich, M.G.2
  • 9
    • 0034106570 scopus 로고    scopus 로고
    • Corner AM, Lamb HM. Lidocaine patch 5%. Drugs 2000;59: 245-249.
    • Corner AM, Lamb HM. Lidocaine patch 5%. Drugs 2000;59: 245-249.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.